Yuting Wang – Trademark Portfolio
Entity Type: 01
Yuting Wang owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ILYBY, JIZISO, SHOBIU, BUYANQI, and DAVUCKO. Of these, 8 are registered. The portfolio spans 7 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 11 (Environmental Control). Headquartered in Heilongjiang.
NO.2, Building 41, C Zone,
Nongken Community, bawuliu, Hulin City,
Heilongjiang 158400 , CN
Showing of trademarks Trademarks
Trademark Classifications
Yuting Wang's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Yuting Wang have?
Yuting Wang has 9 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 abandoned.
What trademark classes does Yuting Wang file in?
Yuting Wang files trademarks across 7 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 11 (Environmental Control), Class 26 (Fancy Goods), Class 41 (Education & Entertainment), Class 21 (Housewares). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Yuting Wang's most well-known trademarks?
Yuting Wang's registered trademark portfolio includes well-known marks such as ILYBY, JIZISO, SHOBIU, BUYANQI, and DAVUCKO. These are among 8 currently registered trademarks in the portfolio.
What is Yuting Wang's trademark registration success rate?
Yuting Wang has a 89% trademark registration rate, with 8 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.